We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Upholds Ruling Against Generic Acular

Law360 (April 12, 2007, 12:00 AM EDT) -- A federal appeals court has affirmed a lower court ruling that barred Apotex Inc. from obtaining regulatory approval to market a generic version of Allergan Inc.’s prescription anti-inflammatory eye-drop solution Acular.

The U.S. Court of Appeals for the Federal Circuit on Monday upheld a June 2006 ruling by a district judge in northern California that held that the effective date of the approval of the defendants’—Apotex Inc., Apotex Corp. and Novex Pharma—Abbreviated New Drug Application seeking permission to market a generic version of Acular could not...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.